Evaluation on cardiovascular disease prevalence in HIV/AIDS patients and risk prediction models application
The coexistence of cardiovascular disease(CVD)in human immunodeficiency virus(HIV)infection people has become a global public health problem.A number of CVD prediction models have been used in domestic and foreign studies to evaluate the morbidity risk in patients.However,their applicability is limited in female populations,HIV-infected patients,and other diseases.The incorporation of specific risk factors is a necessary consideration in this regard.At present,domestic studies on CVD prediction of HIV-infected patients are predominantly cross-sectional design,with relatively small sample sizes and insufficient number of studies,making it difficult to accurately assess the relationship between risk and the model.Therefore,this paper aims to briefly reviews the epidemiological characteristics of HIV-associated CVD and the application evaluation of risk models at home and abroad,in order to provide theoretical basis for clinicians to correctly select risk prediction models and develop specific CVD risk prediction models suitable for HIV-infected patients in their own country.
AIDShuman immunodeficiency virus-infected patientscardiovascular disease riskrisk prediction model